Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Early Pipeline Case Study

Deal Watch October 2018

When writing this bimonthly edition of Medius’s Deal Watch I have been struck by how often the words 'it’s unusual...' have appeared. Most months we focus on the usual and...

- PMLiVE

Is AstraZeneca looking for its next CEO?

Shareholders said to want succession plan in place

- PMLiVE

Boston Scientific makes $4.2bn play for UK’s BTG

Comes shortly after the company acquired US biotech Augmentix

How to create an ethical pharma exhibition stand

At Apex, we have an enviable reputation when it comes to creating eye-catching and engaging exhibition stands that start conversations and boost sales. However, for heavily regulated industries such as...

Apex Events and Exhibitions

- PMLiVE

UK and EU’s future relationship ‘must protect patients’

UK coalition concerned about regulation, data sharing, infectious disease controls

- PMLiVE

Behaviour change – a missing ingredient?

‘Successful and impactful behaviour change requires huge commitment and time’

Porterhouse Medical is raising awareness for pancreatic cancer, here’s why…

Porterhouse Medical Group

- PMLiVE

Fishawack launches two new divisions, Life partners with hygiene charity and ROAD wins new account

Healthcare comms news round-up

Roche Basel Switzerland

Roche builds on Immunocore ImmTAC deal

Extends partnership to target MAGE-A4 protein tumours

- PMLiVE

CHMP backs Sanofi’s all-oral sleeping sickness drug

Sanofi's drug and others given green light by EMA committee

- PMLiVE

Roche pulls EU Tecentriq/Avastin filing in kidney cancer

Another setback for Roche, but CHMP changes its mind on Opdivo/Yervoy

- PMLiVE

Behaviour change: what is the buzz all about?

'The value of behavioural sciences is only fully realised when it is integrated into a broader communications strategy and tactical mix’

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links